Zotefoams PLC
21 March 2006
21 March 2006
Commercial agreement between Zotefoams plc ('Zotefoams') and Sekisui Chemical
Company Limited and its subsidiaries ('Sekisui Group')
With immediate effect, Zotefoams and Sekisui Group have agreed to terminate
their commercial agency relationships in Europe and North America. Sekisui will
continue to act as distributor for Zotefoams' products in Asia until 30 April
2006.
During 2000 and 2001 Zotefoams entered into a number of worldwide sales and
marketing alliances for polyolefin foams with Sekisui Group, who act as
exclusive agent and distributor for Zotefoams in Continental Europe (through
their European subsidiary, Alveo AG ('Alveo')) and Asia respectively. Sekisui
Group also act as an agent for certain of Zotefoams' customers in North America
through its American subsidiary, Voltek LLC.
On 15 December 2005 and on 14 March 2006, Zotefoams announced that it had, for
some time, been in negotiations with Sekisui Group in relation to certain of its
obligations under two of these agreements. Zotefoams announced that while it was
still open to a resolution by other means, it had instigated arbitration
proceedings.
Termination of these arrangements was agreed subject to Zotefoams plc paying
Alveo a reduced termination fee of euro 1.4 million as well as dropping all
disputes due to be heard in arbitration. Zotefoams will assume direct
responsibility for all customer matters in all regions with plans to increase
direct sales resource to support this, although it is envisaged separate
agreements may be appropriate in Asia in the medium term.
In 2005, Zotefoams paid Sekisui Group approximately euro 1.5 million in agent's
commissions (principally to Alveo) under these arrangements. From 20 March 2006,
no further commissions will be earned by Sekisui Group.
Zotefoams is pleased that these disputes have been resolved with Sekisui and
looks forward to working directly with its customers.
Enquiries:
Zotefoams plc 0208-664-1600
David Stirling, Managing Director
Clifford Hurst, Finance Director
Financial Dynamics Limited 0774-602-739 / 0207-831-3113
Sarah MacLeod / Deborah Scott
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.